In PD, biomarkers like α-synuclein and DJ-1 are measured not only in CSF but also in peripheral tissues (e.g., saliva, skin biopsies), reflecting their widespread expression; however, the overlap with other synucleinopathies can complicate interpretation [17]. The gene discussed is PARK7; the disease is synucleinopathy.